Regulation of the components of the 150 kDa IGF binding protein complex incocultures of rat hepatocytes and Kupffer cells by 3 ',5 '-cyclic adenosine monophosphate
Jg. Scharf et al., Regulation of the components of the 150 kDa IGF binding protein complex incocultures of rat hepatocytes and Kupffer cells by 3 ',5 '-cyclic adenosine monophosphate, J CELL PHYS, 186(3), 2001, pp. 425-436
In the circulation, most of IGFs are bound to a high molecular mass complex
of 150 kDa that consists of IGF-I (or IGF-II), IGFBP-3 and the acid-labile
subunit (ALS). Within rat liver, biosynthesis of these components has been
localized to different cell populations with hepatocytes as source of ALS
and nonparenchymal cells (endothelial and Kupffer cells (KC)) as source of
IGFBP-3. In the present study, the regulatory effects of the cAMP analogs d
ibutyryl-cAMP (db-cAMP) and 8-bromo-cAMP (8-br-cAMP) on IGF-I, ALS, and IGF
BP expression were evaluated in primary cultures of rat hepatocytes, KC as
well as in cocultures of hepatocytes and KC. In cocultures, biosynthesis of
IGFBP-3 and ALS was inhibited dose-dependently by db-cAMP and 8-br-cAMP wh
ile that of IGF-I, IGFBP-1, and -4 was stimulated as demonstrated by ligand
and Northern blotting. IGFBP-3 expression in primary cultures of pure KC d
id not respond to cAMP treatment indicating the importance of a cellular in
teraction between KC and hepatocytes for the decreased IGFBP-3 synthesis. T
he inhibition of IGFBP-3 in db-cAMP-treated cocultures was due to a decreas
e of IGFBP-3 mRNA level accompanied by a reduced cellular degradation of IG
FBP-3. We conclude that cAMP stimulate the biosynthesis of IGF-I, IGFBP-1,
and -4 in cocultures of hepatocytes and KC thereby enabling the formation o
f binary IGF/IGFBP complexes while the formation of the 150 kDa complex is
impaired through downregulation of IGFBP-3 and ALS. This complex regulation
may be a prerequisite for the effects of cAMP-dependent hormones on the tr
ansfer of IGFs from circulation to peripheral tissues. (C) 2001 Wiley-Liss,
Inc.